Ovarian Cancer Market Report 2026

Ovarian Cancer Market Overview

• Ovarian Cancer market size has reached to $4.35 billion in 2025 • Expected to grow to $10.02 billion in 2030 at a compound annual growth rate (CAGR) of 18.1% • Growth Driver: Impact Of Rising Female Population On Market • Market Trend: Advancements In AI Platforms For Early Detection Of Ovarian Cancer • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ovarian Cancer Market?

Ovarian cancer refers to a type of cancer that originates in the ovaries, which are the female reproductive organs responsible for producing eggs (ova) and hormones such as estrogen and progesterone. It can develop in different parts of the ovaries, including the surface epithelium, the germ cells, or the stroma. The main types of ovarian cancer are epithelial ovarian tumors, ovarian germ cell tumors, ovarian stromal tumors, and primary peritoneal carcinoma. Epithelial ovarian tumors are a type of ovarian cancer that originates in the epithelial cells, which form the outer lining of the ovaries. The various treatment include chemotherapy, targeted therapy, radiation therapy, immunotherapy, hormonal therapy, and surgery. These are administered through various routes of administration such as oral, parenteral, and other methods, and are used by different end-users, including hospitals, diagnostic centers, drug stores, online pharmacies, and others.

What Is The Ovarian Cancer Market Growth Forecast?

The ovarian cancer market size is expected to see rapid growth in the next few years. It will grow to $10.02 billion in 2030 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to increasing adoption of targeted therapy and immunotherapy, expansion of personalized medicine and genomic profiling, rising use of minimally invasive surgical techniques, growing awareness and early detection programs, increasing investment in ovarian cancer research and diagnostics. Major trends in the forecast period include rising adoption of targeted therapy and immunotherapy, increasing focus on early diagnosis and screening programs, growing use of minimally invasive surgical techniques, expansion of personalized medicine and genomic profiling, increasing awareness about ovarian cancer risk factors.

Global Ovarian Cancer Market Segmentation

1) By Type: Epithelial Ovarian Tumors, Ovarian Germ Cell Tumors, Ovarian Stromal Tumors, Primary Peritoneal Carcinoma 2) By Treatment: Chemotherapy, Targeted Therapy, Radiation Therapy, Immunotherapy, Hormonal Therapy, Surgery 3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration 4) By End-User: Hospitals, Diagnostic Centers, Drug Stores, Online Pharmacies, Other End Users Subsegments: 1) By Epithelial Ovarian Tumors: Serous Carcinoma, Mucinous Carcinoma, Endometrioid Carcinoma, Clear Cell Carcinoma, Brenner Tumors 2) By Ovarian Germ Cell Tumors: Dysgerminoma, Teratoma, Yolk Sac Tumor, Embryonal Carcinoma, Choriocarcinoma 3) By Ovarian Stromal Tumors: Granulosa Cell Tumors, Thecomas, Sertoli-Leydig Cell Tumors 4) By Primary Peritoneal Carcinoma: High-Grade Serous Carcinoma, Low-Grade Serous Carcinoma

What Is The Driver Of The Ovarian Cancer Market?

The increasing female population is expected to propel the growth of the ovarian cancer market going forward. The female population refers to the total number of females living in a specific area or worldwide at a given time. The increasing female population is driven by factors such as higher life expectancy, improved healthcare, and demographic shifts. Ovarian cancer treatment supports the female population by offering surgery, chemotherapy, targeted therapy, and immunotherapy to remove cancerous cells, slow disease progression, alleviate symptoms, and improve survival rates, ultimately enhancing quality of life and providing hope for better long-term outcomes. For instance, in July 2023, according to the UN Division for Inclusive Social Development, women and girls made up about 49.7 percent of the global population. Therefore, increasing female population is driving the growth of the ovarian cancer industry.

Key Players In The Global Ovarian Cancer Market

Major companies operating in the ovarian cancer market are Pfizer Incorporated, Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Bayer Aktiengesellschaft, Sanofi S.A., AstraZeneca PLC, GlaxoSmithKline plc, Eli Lilly and Company, Bristol‑Myers Squibb Company, Boehringer Ingelheim GmbH, Clovis Oncology Inc., Novogen Limited, Oasmia Pharmaceutical AB, Aeterna Zentaris Inc., Allarity Therapeutics Inc., Daiichi Sankyo Inc., Astellas Pharma Inc., Jiangsu HengRui Medicine Co Ltd, ImmunoGen Inc., Verastem Oncology Inc., Sutro Biopharma Inc., Mersana Therapeutics Inc.

Global Ovarian Cancer Market Trends and Insights

Major companies operating in the ovarian cancer market are focusing on advanced solutions, such as AI platforms, to analyze complex medical data with accuracy. An AI platform for ovarian cancer is a technology-driven system that leverages artificial intelligence (AI) and machine learning (ML) to enhance various aspects of ovarian cancer care. These platforms typically integrate medical imaging, genomic data, electronic health records (EHRs), and real-time analytics to support early detection, diagnosis, personalized treatment planning, and patient monitoring. For instance, in February 2024, AIIMS Delhi, in collaboration with CDAC Pune, an Indian-based organization, launched iOncology.ai, an indigenously developed AI platform for early detection of breast and ovarian cancer. This platform uses deep learning models to analyze radiological and histopathological images with high accuracy, aiming to improve early diagnosis and survival rates. Already deployed in several hospitals, iOncology.ai integrates with the healthcare system to provide risk assessments and recommend mammograms, particularly for women in rural areas, and is part of a broader initiative to integrate AI into healthcare and reduce pressure on medical systems.

What Are Latest Mergers And Acquisitions In The Ovarian Cancer Market?

In February 2024, AbbVie Inc., a US-based biopharmaceutical company, acquired ImmunoGen Inc. for an undisclosed amount. With this acquisition, AbbVie aimed to strengthen its oncology portfolio by integrating ImmunoGen's innovative antibody-drug conjugate, ELAHERE, alongside other promising cancer therapies. ImmunoGen Inc. is a US-based biotechnology company specializing in the development of antibody-drug conjugates (ADCs) for the treatment of ovarian cancer.

Regional Outlook

North America was the largest region in the ovarian cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Ovarian Cancer Market?

The ovarian cancer market consists of revenues earned by entities by providing services such as screening and early detection services, diagnostic imaging services, surgical treatment services, clinical trial services, and palliative and supportive care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The ovarian cancer market also includes sales of taxane-based chemotherapy, surgical treatment devices, radiation therapy equipment, angiogenesis inhibitors, and checkpoint inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ovarian Cancer Market Report 2026?

The ovarian cancer market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ovarian cancer industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.